Skip to content

STELLA LÉON

Active Private limited companyfounded 2024active for 2 yearsKorporaaldreef 36, 1180 UccleKBO/BCE: BE 1013.005.246

Overview

Lifetime

1 annual account with figures
peak €762 (2024)
€762 
peak €74 (2024)
€74 
peak €3,074 (2024)
€3,074 
€23,570 
Board1 name since 2024
Documentsfilings and deeds
26-06-202535 days before the deadline
2024abbreviated format
Incorporation 03-091 establishment registeredFirst year with figures

Key points

from the 2024 annual accounts

Turnover

≈ €5,100 estimated

The abbreviated format states no turnover.

Debts

€23,570 88% of the balance sheet

Position in the sector

€3,074

Less equity than 95% of companies in human health. Sector median €510,754 · 2,143 companies.

Checked score

79
Excellent
Financially stronger than 15% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 09-2025: < 0.1%lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: 0.1%▲ +0.1 percentage points vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.2%▲ +0.1 percentage points vs 08-2026 10-2026: 0.4%▲ +0.2 percentage points vs 09-2026highest value 11-2026: 0.4%● unchanged vs 10-2026highest value

Financial strength
Weak

37equity 11.5% of total assets
51short-term debt 88.5% · cash 71.3%
38return on assets 0.3%

Score breakdown

raises risk
Figures for financial year 2024 (filed on 26-06-2025)
Founded in 2024
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 1.13, cash €19,000
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 15% of them on solvency, 24% on liquidity and 6% on profitability.

The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2024.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 2,542 companies had the same profile as STELLA LÉON has now. Each dot stands for 7 companies, two years later.

95.0%
were still trading
1.2%
stopped another way
3.5%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet

Another 0.3% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of STELLA LÉON itself is lower: 0.4% within 12 months. It rests on far more data about STELLA LÉON than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,542 companies, not a prediction for STELLA LÉON. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Figures for financial year 2024 (filed on 26-06-2025)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.13, cash €19,000
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 2143 sector peers (2024).
NBB · sector comparison
Position among 2143 sector peers
Solvency
better than 13%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-06-2025, 35 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2024
35 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its 2024 accounts 35 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Board and ownership

  • BERENBAUM Tara Yvonne Esther 100 sharesdeed of 03-09-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1013005246
Incorporation Founding capital of €3,000, 100 shares · Founder: BERENBAUM Tara Yvonne Esther (comparante) · Appointment: BERENBAUM Tara Yvonne Esther (director) · published on 03-09-2024 · Gazette deed
First establishment Korporaaldreef 36, Uccle
All 4 events

Comparable companies

same main activity, similar in size and age
Company
STELLA LÉON Uccle €26,644 €762 11.5% -
AMA CHIRURGIE GENERALE Mettet €26,416 -€1,798 -48.7% -
HealthEra Lievegem €22,854 -€23,641 -107.1% -
MB-NDV Ghent €27,788 €309 8.5% -
Health Center Hoeilaart Hoeilaart €31,707 -€7,571 -9.4% -
Medical Flore Gheysen Ghent €35,463 -€594 3.6% -
Dr. Caroline Verheyden Hove €35,489 -€40,035 -120.7% -

These companies have the same main activity as STELLA LÉON: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €22,900 and €35,500, founded between 2023 and 2025.

Official details

Source: KBO
Status
Active since 30-08-2024Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.363.457.3591180 Uccle, since 30-08-2024
Financial year end
31 December
Peppol
Reachable since 16-03-2026
Company details

Annual accounts 2024

€762
€74
€3,074
€26,644
Filing
Filed on 26-06-2025, 35 days before the end of the filing period
Financials

Insights on STELLA LÉON

STELLA LÉON has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €3,074 and a net result of €74.

Its solvency ranks better than 13% of 2,143 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 0.4% (very low).

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2024

abbreviated format, filed on 26-06-2025, 35 days before the deadline
€762
€375
€74
€3,074
11.5%
1.13

Turnover and EBIT margin are not published. The abbreviated format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €5,100. Estimated: probably between €3,100 and €8,900.

Balance sheet

balance sheet total €26,644 on 31-12-2024
What the company ownsHow it is paid for

Position in the sector

11.5%

Higher than 13% of 2,143 companies in 2024.

1.13

Higher than 21% of 2,110 companies in 2024.

0.3%

Higher than 10% of 2,104 companies in 2024.

STELLA LÉON Middle half of the sector 80% of the sector Abbreviated accounts in human health (NACE 86)

Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: bottom quarter

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2024
Balance sheet: assets
20/58 26,644
29/58 26,644
40/41 1,700
41 1,700
54/58 19,000
490/1 5,945
Balance sheet: equity and liabilities
10/49 26,644
10/15 3,074
10/11 3,000
14 74
17/49 23,570
42/48 23,570
47/48 23,570
Income statement
9900 762
640/8 387
9901 375
75/76B 3
75 3
65/66B 3
65 3
9903 374
67/77 300
9904 74
9905 74
Appropriation of the result
9906 74
Document PDF

The notes to these accounts have 1 item. You find them in the accounts filed with the NBB.

Source: Annual accounts 2024 at the NBB, filed on 26-06-2025.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2024 abbreviated format 26-06-2025 2025-00180128 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2024
3,074
11.5%
1.13
7.67
2.4%
0.3%

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on STELLA LÉON

Debt's share of the balance-sheet total is 88.5%.

Board & ownership

Board

1 director, since incorporation
Director
appointed by deed of 03-09-2024 term without a fixed end
listed in the 2024 annual accounts, filed on 26-06-2025
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 11. Pouvoirs de l’organe d’administration Lorsque la société ne comprend qu’un seul actionnaire, l’actionnaire unique pourra être…”
deed of 03-09-2024

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
Board
Mandates as a list
  • BERENBAUM Tara Yvonne Esther
    • Director, appointed by deed of 03-09-2024, still in office

See the board, name and registered office on a given date →

Control

This company
STELLA LÉON
Equity €3,074
Profit €74 in 2024

Capital

Contribution
€3,000
Shares
100
Contribution per share
€30
Equity per share
€30.74 in 2024
Source
deed of 03-09-2024

Articles of association

deed of 03-09-2024 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
1 director
“Pluralité d’actionnaires ou co-administrateur, mandat automatiquement limité à 6 ans, renouvelable, actionnaire unique pourra être nommé…”
Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
100 shares
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Friday of June at 14:00

Shareholders

At incorporation deed of 03-09-2024 ↗

Network & group

No group

STELLA LÉON has no parent and no holdings in its annual accounts. BERENBAUM Tara Yvonne Esther is the only director. STELLA LÉON shares no director with another company.

The LEI register names no parent.

At the same address

Korporaaldreef 36, 1180 Uccle · 1 other company
Jonathan van den Berg
registered office since 11-06-2013 · founded in 2013
total assets €1.2m (2025)
0535.593.121

Timeline

Timeline

4 events since 2024
2026
Registered in the Peppol Directory Reachable for e-invoices through 0208:1013005246
2025
Annual accounts 2024 filed NBBabbreviated format · 35 days before the deadline
2024
IncorporationFounding capital of €3,000, 100 shares · Founder: BERENBAUM Tara Yvonne Esther (comparante) · Appointment: BERENBAUM Tara Yvonne Esther (director) · published on 03-09-20244 points ▸

Open the deed in the Belgian Official Gazette

First establishment Korporaaldreef 36, Uccle

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

Company details

Identity

Enterprise number
1013.005.246
VAT number
BE 1013.005.246
Peppol ID
0208:1013005246
Other Peppol ID
9925:BE1013005246
LEI code
254900PTLT879UTQX831 live in the LEI register
Legal form
Private limited company
Status
Active, normal situation
Founded
30-08-2024
Financial year
ends on 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Friday of June at 14:00
deed of 03-09-2024 (in French)
Peppol
Reachable since 16-03-2026Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
STELLA LÉON in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 03-09-2024 (in French)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Région de Bruxelles-Capitale”
deed of 03-09-2024 (in French)

Activities

NACEBEL 2025
86220 Specialist medical practice main activity
Codes under NACEBEL 2008
86220 Human health activities main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
“L’exercice de la médecine en générale. Les associés veillent à prendre toutes les mesures utiles en vue de garantir la continuité des soins…”
10 activities
  1. L’exercice de la médecine en générale. Les associés veillent à prendre toutes les mesures utiles en vue de garantir la continuité des soins au profit des patients, pour chacune des spécialités exercées au sein de la société.
  2. L’exercice de la médecine par les associés qui la composent, dans le respect de la déontologie médicale ;
  3. L’organisation de services généraux nécessaires ou utiles à l’exercice de l’activité médicale, et notamment l’organisation d’un secrétariat médical ;
  4. La gestion d’un centre médical, en ce compris l’acquisition, la location, le leasing et l’entretien de matériel médical, la facturation et la perception des honoraires médicaux à son nom et pour son compte, la mise à disposition des médecins travaillant dans le cadre de la société du matériel et de tout ce qui est nécessaire à l’exercice de l’Art de guérir ;
  5. L’acquisition, la construction, la location et le leasing de toutes les installations nécessaires ou utiles à l’exercice de l’activité de la société, en ce compris tous bâtiments, et plus généralement toute l’infrastructure matérielle complète au sens le plus large, afin que celle-ci puisse notamment être mise à la disposition du ou des médecins associés ;
  6. La défense des intérêts professionnels, tant moraux que matériels, des médecins travaillant dans le cadre de la société et tous moyens leur permettant de se perfectionner dans leur activité professionnelle afin d’assurer aux patients une pratique médicale d’un niveau qualitativement élevé.
  7. Favoriser la recherche scientifique, en organisant des activités de recyclage et en nouant avec tous les organismes poursuivant les mêmes buts les relations et les contacts nécessaires ou utiles à la réalisation de son objet.
  8. Exercer toutes activités susceptibles de favoriser la réalisation de son objet social et moyennant l’accord du Conseil Provincial compétent de l’Ordre des Médecins, s’intéresser par toutes voies de droit dans toutes entreprises ayant un objet identique, analogue ou connexe au sien ou qui soit de nature à favoriser le développement de sa propre activité.
  9. Faire toutes opérations financières, mobilières ou immobilières se rapportant directement ou indirectement à son objet ou pouvant en faciliter la réalisation, pour autant que les dispositions du Code de déontologie médicale soient respectées.
  10. À titre accessoire, la constitution, la gestion et la valorisation d’un patrimoine mobilier et immobilier, notamment par l’achat, la vente, la location, la mise en location ou la construction, le tout au sens le plus large, pour autant que n’en soient altérés sa vocation prioritairement médicale, et que ces opérations s’inscrivant dans les limites d’une gestion en personne prudente et raisonnable, n’aient pas un caractère répétitif et commercial.
deed of 03-09-2024 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
Korporaaldreef 36 registered office 1180 Uccle 30-08-2024 2.363.457.359

Buildings and parcels at the address

Ground area
1,164 m²
Buildings
153 m²
Volume, LiDAR
928 m³
Tallest building
13.1 m
Buildings to scale, each on its own parcel
153 m², 13.1 m 153 m², 13.1 m

Location

registered office establishment The establishment unit on the map
2 companies at this address See who is registered here

Parcels

Cadastral parcelArea Buildings Height / floors
21614H0010/00D0311,164 m² 1 · 153 m² 13.1 m · 2